Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription

Articles published in
    October 2017
  1. ERCAN E
    Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality.
    Atherosclerosis. 2017 Oct 23. pii: S0021-9150(17)31348.
    >> Share

    September 2017
  2. CHUNG CM, Lin MS, Chang CH, Cheng HW, et al
    Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.
    Atherosclerosis. 2017 Sep 27. pii: S0021-9150(17)31288.
    >> Share

  3. POKHAREL Y, Sharma PP, Qintar M, Lu Y, et al
    High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
    Atherosclerosis. 2017;266:16-23.
    >> Share

  4. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
    Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study.
    Atherosclerosis. 2017;265:147-154.
    >> Share

    August 2017
  5. GITT AK, Lautsch D, Ferrieres J, De Ferrari GM, et al
    Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Atherosclerosis. 2017;266:158-166.
    >> Share

    June 2017
  6. MOXON JV, Jones RE, Wong G, Weir JM, et al
    Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations.
    Atherosclerosis. 2017;263:301-308.
    >> Share

  7. HUANG F, Liu Y, Yang X, Che D, et al
    Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
    Atherosclerosis. 2017;263:184-191.
    >> Share

    May 2017
  8. ERIKSSON OSTMAN M, Calais F, Rosenblad A, Frobert O, et al
    Prognostic impact of subclinical or manifest extracoronary artery diseases after acute myocardial infarction.
    Atherosclerosis. 2017;263:53-59.
    >> Share

  9. FERNANDEZ-SANLES A, Sayols-Baixeras S, Subirana I, Degano IR, et al
    Association between DNA methylation and coronary heart disease or other atherosclerotic events: A systematic review.
    Atherosclerosis. 2017 May 18. pii: S0021-9150(17)30225.
    >> Share

  10. HARRIS WS, Del Gobbo L, Tintle NL
    The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies.
    Atherosclerosis. 2017;262:51-54.
    >> Share

  11. NOLLET E, Hoymans VY, Rodrigus IR, De Bock D, et al
    Accelerated cellular senescence as underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease.
    Atherosclerosis. 2017;260:138-146.
    >> Share

    April 2017
  12. ALBREKTSEN G, Heuch I, Lochen ML, Thelle DS, et al
    Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromso Study 1979-2012.
    Atherosclerosis. 2017;261:52-59.
    >> Share

    March 2017
  13. MATSUNAGA M, Yatsuya H, Iso H, Yamashita K, et al
    Similarities and differences between coronary heart disease and stroke in the associations with cardiovascular risk factors: The Japan Collaborative Cohort Study.
    Atherosclerosis. 2017 Mar 6. pii: S0021-9150(17)30093.
    >> Share

    February 2017
  14. LIU LP, Cheng K, Ning MA, Li HH, et al
    Association between peripheral blood cells mitochondrial DNA content and severity of coronary heart disease.
    Atherosclerosis. 2017 Feb 20. pii: S0021-9150(17)30065.
    >> Share

  15. CHRISTIANSEN MK, Nyegaard M, Pedersen LN, Larsen SB, et al
    A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering.
    Atherosclerosis. 2017;257:172-178.
    >> Share

  16. OSAWA K, Nakanishi R, Budoff MJ
    Is there a role for coronary artery calcification scoring in primary prevention of cerebrovascular disease?
    Atherosclerosis. 2017;257:279-287.
    >> Share

  17. LIN JF, Wu S, Juang JJ, Chiang FT, et al
    IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
    Atherosclerosis. 2017;257:71-77.
    >> Share

  18. DE VRIES MA, Trompet S, Mooijaart SP, Smit RA, et al
    Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.
    Atherosclerosis. 2017;257:16-21.
    >> Share

  19. KIM J, Budoff MJ, Nasir K, Wong ND, et al
    Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2017;257:1-8.
    >> Share

  20. LEE EM, Choi MH, Seo HS, Kim HK, et al
    Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
    Atherosclerosis. 2017;257:195-200.
    >> Share

  21. CHEEZUM MK, Kim A, Bittencourt MS, Kassop D, et al
    Association of tobacco use and cessation with coronary atherosclerosis.
    Atherosclerosis. 2017;257:201-207.
    >> Share

    January 2017
  22. WIDHALM K, Benke IM, Fritz M, Geiger H, et al
    Homozygous familial hypercholesterolemia: Summarized case reports.
    Atherosclerosis. 2017;257:86-89.
    >> Share

  23. BRUCKERT E, Kalmykova O, Bittar R, Carreau V, et al
    Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
    Atherosclerosis. 2017;257:130-137.
    >> Share

  24. BOS S, Duvekot MH, Ten Kate GR, Verhoeven AJ, et al
    Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
    Atherosclerosis. 2017;256:62-66.
    >> Share

  25. NONIN S, Iwata S, Sugioka K, Fujita S, et al
    Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.
    Atherosclerosis. 2017;256:29-34.
    >> Share

    December 2016
  26. LEE DH, Chun EJ, Hur JH, Min SH, et al
    Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
    Atherosclerosis. 2016;257:47-54.
    >> Share

    Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.
    Atherosclerosis. 2016;255:145-155.
    >> Share

    October 2016
  28. LU Y, Cheng Z, Zhao Y, Chang X, et al
    Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.
    Atherosclerosis. 2016;254:215-227.
    >> Share

    September 2016
  29. GUO XY, Li N, Du X, Bai R, et al
    Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis.
    Atherosclerosis. 2016;254:1-7.
    >> Share

  30. ELAJAMI TK, Giuseffi J, Avila MD, Hovnanians N, et al
    Parity, coronary heart disease and mortality in the old order Amish.
    Atherosclerosis. 2016;254:14-19.
    >> Share

  31. SANTOS-GALLEGO CG, Wallert M, Peter K
    Myocardial infarction caused by surgery: Blame inflammation not the surgeon.
    Atherosclerosis. 2016 Sep 1. pii: S0021-9150(16)31312.
    >> Share

    August 2016
  32. ZENG L, Dang TA, Schunkert H
    Genetics links between transforming growth factor beta pathway and coronary disease.
    Atherosclerosis. 2016 Aug 25. pii: S0021-9150(16)31290.
    >> Share

    July 2016
  33. VISSERS LE, Waller MA, van der Schouw YT, Hebert JR, et al
    The relationship between the dietary inflammatory index and risk of total cardiovascular disease, ischemic heart disease and cerebrovascular disease: Findings from an Australian population-based prospective cohort study of women.
    Atherosclerosis. 2016 Jul 30. pii: S0021-9150(16)31230.
    >> Share

  34. YUBERO-SERRANO EM, Delgado-Lista J, Alcala-Diaz JF, Garcia-Rios A, et al
    A dysregulation of glucose metabolism control is associated with carotid atherosclerosis in patients with coronary heart disease (CORDIOPREV-DIAB study).
    Atherosclerosis. 2016 Jul 16. pii: S0021-9150(16)31204.
    >> Share

    June 2016
  35. DISTELMAIER K, Schrutka L, Wurm R, Seidl V, et al
    Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction.
    Atherosclerosis. 2016 Jun 24. pii: S0021-9150(16)30282.
    >> Share

  36. LOUWE MC, Lammers B, Frias MA, Foks AC, et al
    Abca1 deficiency protects the heart against myocardial infarction-induced injury.
    Atherosclerosis. 2016;251:159-163.
    >> Share

  37. MENZEL J, di Giuseppe R, Biemann R, Wittenbecher C, et al
    Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study.
    Atherosclerosis. 2016 Jun 2. pii: S0021-9150(16)30243.
    >> Share

    May 2016
  38. MANTAS D, Markopoulos C
    Screening mammography: Usefulness beyond early detection of breast cancer.
    Atherosclerosis. 2016;248:1.
    >> Share

  39. PARK SJ, Yang HM, Seo KW, Choi SY, et al
    The relationship between coronary atherosclerosis and body fat distribution measured using dual energy X-ray absorptiometry.
    Atherosclerosis. 2016;248:190-5.
    >> Share

  40. YONGSAKULCHAI P, Settasatian C, Settasatian N, Komanasin N, et al
    Association of combined genetic variations in PPARgamma, PGC-1alpha, and LXRalpha with coronary artery disease and severity in Thai population.
    Atherosclerosis. 2016;248:140-8.
    >> Share

  41. CHENG JM, Oemrawsingh RM, Garcia-Garcia HM, Boersma E, et al
    PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study.
    Atherosclerosis. 2016;248:117-22.
    >> Share

    Translational atherosclerosis research: From experimental models to coronary artery disease in humans.
    Atherosclerosis. 2016;248:110-6.
    >> Share

  43. CAHILL PA, Redmond EM
    Vascular endothelium - Gatekeeper of vessel health.
    Atherosclerosis. 2016;248:97-109.
    >> Share

    April 2016
  44. MIRANDA CH, de Carvalho Borges M, Schmidt A, Marin-Neto JA, et al
    Evaluation of the endothelial glycocalyx damage in patients with acute coronary syndrome.
    Atherosclerosis. 2016;247:184-8.
    >> Share

  45. OEMRAWSINGH RM, Cheng JM, Garcia-Garcia HM, Kardys I, et al
    High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study.
    Atherosclerosis. 2016;247:135-41.
    >> Share

  46. DAI J, Tian J, Hou J, Xing L, et al
    Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: An optical coherence tomography study.
    Atherosclerosis. 2016;247:111-7.
    >> Share

  47. NAITO R, Miyauchi K, Konishi H, Tsuboi S, et al
    Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008.
    Atherosclerosis. 2016;247:105-10.
    >> Share

  48. SKAGEN K, Troseid M, Ueland T, Holm S, et al
    The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Atherosclerosis. 2016;247:64-9.
    >> Share

  49. CAVALCANTE R, Bittencourt MS, Pinheiro TL, Falcao BA, et al
    Validation of coronary computed tomography angiography scores for non-invasive assessment of atherosclerotic burden through a comparison with multivessel intravascular ultrasound.
    Atherosclerosis. 2016;247:21-7.
    >> Share

    February 2016
  50. MULDERS TA, Taraboanta C, Franken LC, van Heel E, et al
    Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease.
    Atherosclerosis. 2016;245:155-60.
    >> Share

  51. GUO L, Wang L, Li H, Yang X, et al
    Down regulation of GALNT3 contributes to endothelial cell injury via activation of p38 MAPK signaling pathway.
    Atherosclerosis. 2016;245:94-100.
    >> Share

  52. OLSON F, Engborg J, Gronhoj MH, Sand NP, et al
    Association between high-sensitive troponin I and coronary artery calcification in a Danish general population.
    Atherosclerosis. 2016;245:88-93.
    >> Share

  53. SUH B, Park S, Shin DW, Ahn H, et al
    Early repolarization is associated with significant coronary artery stenosis in asymptomatic adults.
    Atherosclerosis. 2016;245:50-3.
    >> Share

  54. VAGNARELLI F, Corsini A, Lorenzini M, Ortolani P, et al
    Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes.
    Atherosclerosis. 2016;245:43-9.
    >> Share

  55. CRAIEM D, Chironi DG, Casciaro ME, Sirieix ME, et al
    Association of thoracic aorta calcium and non cardiac vascular events in cardiac disease-free individuals.
    Atherosclerosis. 2016;245:22-7.
    >> Share

    January 2016
  56. OGITA M, Miyauchi K, Kasai T, Tsuboi S, et al
    Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
    Atherosclerosis. 2016;244:216-21.
    >> Share

  57. SAELY CH, Leiherer A, Muendlein A, Vonbank A, et al
    High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.
    Atherosclerosis. 2016;244:38-43.
    >> Share

    December 2015
  58. RHEE EJ, Kim JH, Park HJ, Park SE, et al
    Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study.
    Atherosclerosis. 2015;245:132-138.
    >> Share

    November 2015
  59. CHEN X, Bakillah A, Zhou L, Pan X, et al
    Nitrated apolipoprotein AI/apolipoprotein AI ratio is increased in diabetic patients with coronary artery disease.
    Atherosclerosis. 2015;245:12-21.
    >> Share

    October 2015
  60. PURI R, Nissen SE, Menon V, Shao M, et al
    Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
    Atherosclerosis. 2015;243:553-559.
    >> Share

    September 2015
  61. MOURA FA, Figueiredo VN, Teles BS, Barbosa MA, et al
    Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
    Atherosclerosis. 2015;243:124-130.
    >> Share

  62. SHIN DG, Han SM, Kim DI, Rhee MY, et al
    Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
    Atherosclerosis. 2015;243:53-58.
    >> Share

  63. TZIOMALOS K, Giampatzis V, Bouziana SD, Spanou M, et al
    Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.
    Atherosclerosis. 2015;243:65-70.
    >> Share

  64. BARKAS F, Elisaf M, Milionis H
    Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
    Atherosclerosis. 2015;243:60-64.
    >> Share

    August 2015
  65. YU HH, Chen PC, Yang YH, Wang LC, et al
    Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
    Atherosclerosis. 2015;243:11-18.
    >> Share

    July 2015
  66. PRUDENTE S, Bailetti D, Mendonca C, Mannino GC, et al
    Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.
    Atherosclerosis. 2015;242:334-339.
    >> Share

  67. TANAKA A, Ishii H, Oshima H, Narita Y, et al
    Inverse association between diabetes and aortic dilatation in patients with advanced coronary artery disease.
    Atherosclerosis. 2015;242:123-127.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016